Phase II study of everolimus (RAD001) in previously treated small cell lung cancer

Ahmad Tarhini, Athanasios Kotsakis, William Gooding, Yongli Shuai, Daniel Petro, David Friedland, Chandra P. Belani, Sanja Dacic, Athanassios Argiris

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of everolimus (RAD001) in previously treated small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences